COMMUNIQUÉS West-GlobeNewswire

-
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
25/03/2025 -
Hapbee - The Future of Wellness Tech - Takes Center Stage With Gary Brecka on ‘The Ultimate Human’ Podcast
25/03/2025 -
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
25/03/2025 -
Seattle Plastic Surgery Now Offers Deep Plane Facelift
25/03/2025 -
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Further Strengthens Scientific Advisory Board With Appointment of Dr. Dan J. Stein
25/03/2025 -
Leylah Annie & Family Foundation Partners with First Serve Miami to Empower Local Youth Through Tennis
25/03/2025 -
Lipozem Complaints & Side Effects (URGENT) Buyers Reveal Unexpected Truths Behind Its Real Effectiveness & Safety
25/03/2025 -
USAHS Faculty and Occupational Therapist Dr. Sabina Khan Receives the 2025 Vince Hutchins Leadership Award
25/03/2025 -
Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)
25/03/2025 -
PathAI Showcases AI-Powered Pathology Innovations at the United States and Canadian Academy of Pathology (USCAP) 114th Annual Meeting
25/03/2025 -
LiveWorld Reports 2024 Financial Results
25/03/2025 -
Shineco Announces Acquisition of Medical Device Company
25/03/2025 -
Emerald Isle Health & Recovery Announces New Chief Executive Officer
25/03/2025 -
Oncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and IL-2, Highlights Findings at SWCR 2025 Conference
25/03/2025 -
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada
25/03/2025 -
Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity
25/03/2025 -
Marius Pharmaceuticals Strengthens IP Portfolio with New KYZATREX® (testosterone undecanoate) CIII Capsules Formulation Patent
25/03/2025 -
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
25/03/2025 -
Digital Utilities Ventures Acquires Lifestyle Dock Company, and Expands Market Reach for Easy NanoVoid™ Technology
25/03/2025
Pages